COMMUNIQUÉS West-GlobeNewswire

Dova Pharmaceuticals to Announce Second Quarter 2018 Financial Results on August 9, 2018
26/07/2018
DURHAM, N.C., July 26, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ:DOVA) will host a conference call on Thursday, August 9, 2018 at 4:30 p.m. ET to discuss second quarter 2018 financial results and [...]
electroCore, Inc. to Report Second Quarter Financial Results on August 13, 2018
26/07/2018
BASKING RIDGE, N.J., July 26, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (“electroCore”) (Nasdaq:ECOR), a commercial-stage bioelectronic medicine company, today announced that it will release financial results for the [...]
Loop Industries Expands Into Cosmetics Sector With L’Oréal Group
26/07/2018
TERREBONNE, Quebec, July 26, 2018 (GLOBE NEWSWIRE) -- Loop Industries, Inc. (Nasdaq:LOOP), a global leader in sustainable packaging innovation, announced that it has signed a Letter of Intent with L’Oréal Group, the [...]
LeMaitre Q2 2018 Record Sales $27.0mm (+5%), Record EPS $0.43 (+86%)
26/07/2018
BURLINGTON, Mass., July 26, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q2 2018 results, provided guidance and announced a $0.07/ [...]
Retrophin Reports Second Quarter 2018 Financial Results and Announces CEO Transition Plan
26/07/2018
Patients continue to enroll in Phase 3 FORT Study of fosmetpantotenate in PKAN and Phase 3 DUPLEX Study of sparsentan in FSGS Phase 2 proof-of-concept study of CNSA-001 in patients with PKU set to initiate; top-line [...]
Evolus to Release Second Quarter 2018 Financial Results on Thursday, August 2, 2018
26/07/2018
IRVINE, Calif., July 26, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ:EOLS) (“Evolus” or the “Company”), a company dedicated to aesthetic medicine, today announced that it will release 2018 second quarter financial [...]
Harvard Bioscience Reports Second Quarter 2018 Financial Results
26/07/2018
-Reports record GAAP and adjusted non-GAAP revenue of $31.5 million and $31.6 million, respectively, an increase of 66% and 25%, respectively- HOLLISTON, Mass., July 26, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc [...]
Achaogen Announces Strategic Update to Align Operations with Commercial and Clinical Development Priorities
26/07/2018
-- Restructuring to improve cost structure and focus corporate priorities to reduce overall capital needs -- -- Commercial and Medical Affairs teams unchanged by restructuring as the Company executes on U.S. commercial [...]
Cytokinetics, Inc. Reports Second Quarter 2018 Financial Results
26/07/2018
Phase 2 Study of Reldesemtiv in Patients with SMA Showed Potentially Clinically Meaningful Effects on Six Minute Walk Distance and Maximal Expiratory Pressure Results from Phase 2 Clinical Trial of Reldesemtiv in [...]
Adaptimmune to Report Second Quarter 2018 Financial Results and Business Update on Thursday August 2, 2018
26/07/2018
PHILADELPHIA and OXFORD, United Kingdom, July 26, 2018 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, will announce financial results for the Second Quarter [...]
NANOBIOTIX signs a 40 M€ non-dilutive financing agreement with the European Investment Bank
26/07/2018
NANOBIOTIX SIGNS A 40 M€ NON-DILUTIVE FINANCING AGREEMENT WITH THE EUROPEAN INVESTMENT BANK Acceleration of company's priorities in head & neck clinical development and market preparation Non-dilutive funding to [...]
NANOBIOTIX signe un accord de financement non-dilutif de 40M€ avec la Banque Européenne d'Investissement
26/07/2018
NANOBIOTIX SIGNE UN ACCORD DE FINANCEMENT NON-DILUTIF DE 40M€ AVEC LA BANQUE EUROPEENNE D'INVESTISSEMENT Accélération des priorités de la Société : développement clinique de l'indication des cancers tête et cou et [...]
HEXO Makes Strategic Investment in Premier Western Canadian Retail Cannabis Operation, Fire & Flower
26/07/2018
GATINEAU, Quebec, July 26, 2018 (GLOBE NEWSWIRE) -- The Hydropothecary Corporation (“HEXO” or the “Company”) (TSX:HEXO) is pleased to announce that it has made a strategic $10 million investment into the independent [...]
HEXO fait un investissement stratégique dans Fire & Flower, principal détaillant de cannabis dans l’Ouest canadien
26/07/2018
GATINEAU, Québec, 26 juill. 2018 (GLOBE NEWSWIRE) -- La société Hydropothecary (« HEXO » ou la « Société ») (TSX:HEXO) annonce qu’elle a investi 10 millions de dollars dans Fire & Flower Inc. (« Fire & Flower [...]
UPDATE: REVA Enters Peripheral Artery Disease Space With First-Ever CE Mark of a Bioresorbable Scaffold for Below the Knee Therapy
26/07/2018
SAN DIEGO, July 26, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, today announced that its MOTIV™ [...]
Adamas to Announce Second Quarter 2018 Financial Results and Host Conference Call on August 2, 2018
26/07/2018
EMERYVILLE, Calif., July 26, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced that the company will report second quarter 2018 financial results on Thursday, August 2, 2018, after [...]
Ziopharm Oncology Board Responds to Recent Stock Price Decline
26/07/2018
- Executing on clinical and business development with plans to add new Board members and expand management team - Annual meeting of stockholders is Sept. 18 BOSTON, July 26, 2018 (GLOBE NEWSWIRE) -- Ziopharm Oncology , [...]
Sharecare acquires Window Channel Network, closes investment from Wells Fargo Strategic Capital
26/07/2018
Digital health company’s twelfth acquisition expands content capabilities in digital mindfulness, relaxation and meditation $20 million investment from Wells Fargo Strategic Capital brings Sharecare’s total funding to $ [...]
GUERBET : Revenue at June 30 2018
26/07/2018
€415.7M at constant exchange rates: +2.1% Villepinte, 26 July 2018 - Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, is reporting revenue of €389.6M for the first [...]

Pages